We are live on ! Find out more
PCM

Peregrine Capital Management Portfolio holdings

AUM $3.08B
1-Year Est. Return 29.51%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+29.51%
3 Year Est. Return
+95.04%
5 Year Est. Return
+107.83%
10 Year Est. Return
+715.34%
AUM
$5.58B
AUM Growth
+$184M
Cap. Flow
-$168M
Cap. Flow %
-3.01%
Top 10 Hldgs %
14.71%
Holding
368
New
29
Increased
65
Reduced
177
Closed
32

Top Buys

Rank Stock Value
1
TWLO icon
Twilio
TWLO
+$35.3M
2
ETSY icon
Etsy
ETSY
+$34.9M
3
JRVR icon
James River Group Holdings
JRVR
+$22.4M
4
SFM icon
Sprouts Farmers Market
SFM
+$18.9M
5
TDOC icon
Teladoc Health
TDOC
+$18.8M

Top Sells

Rank Stock Value
1
SPLK
Splunk Inc
SPLK
+$39.1M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$36.3M
3
TYL icon
Tyler Technologies
TYL
+$29.3M
4
NUAN
Nuance Communications, Inc.
NUAN
+$26.6M
5
WBS icon
Webster Financial
WBS
+$23.4M

Sector Composition

Rank Sector Weight
1 Technology 20.82%
2 Healthcare 17.63%
3 Financials 14.42%
4 Consumer Discretionary 12.71%
5 Industrials 11.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
THRY icon
226
Thryv Holdings
THRY
$96.4M
$11.1M 0.2%
+310,148
New +$8.76M
FA icon
227
First Advantage
FA
$3.68B
$10.8M 0.19%
+544,266
New +$11M
MRTX
228
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$10.5M 0.19%
65,161
+4,774
+8% +$767K
DK icon
229
Delek US
DK
$3.91B
$10.5M 0.19%
484,174
+75,619
+19% +$1.71M
EBIX
230
DELISTED
Ebix Inc
EBIX
$10.4M 0.19%
306,978
-32,215
-9% -$997K
FORM icon
231
FormFactor
FORM
$9.3B
$10M 0.18%
274,634
-14,349
-5% -$566K
NVCR icon
232
NovoCure
NVCR
$2.03B
$9.93M 0.18%
44,747
-28,133
-39% -$5.47M
VC icon
233
Visteon
VC
$2.84B
$9.87M 0.18%
81,582
-84,313
-51% -$10.1M
MNRO icon
234
Monro
MNRO
$374M
$9.69M 0.17%
152,516
-9,903
-6% -$654K
DY icon
235
Dycom Industries
DY
$12.2B
$9.65M 0.17%
129,456
-5,629
-4% -$485K
TPTX
236
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$9.6M 0.17%
122,983
+25,968
+27% +$1.92M
ARNA
237
DELISTED
Arena Pharmaceuticals Inc
ARNA
$9.52M 0.17%
139,530
-7,371
-5% -$480K
EBS icon
238
Emergent Biosolutions
EBS
$229M
$9.51M 0.17%
151,000
-5,113
-3% -$328K
TLS icon
239
Telos
TLS
$318M
$9.51M 0.17%
+279,558
New +$9.42M
AXSM icon
240
Axsome Therapeutics
AXSM
$11.4B
$9.37M 0.17%
138,935
+10,530
+8% +$632K
DV icon
241
DoubleVerify
DV
$2.03B
$9.14M 0.16%
+215,805
New +$7.69M
OPLN
242
Openlane
OPLN
$4.58B
$9.12M 0.16%
519,656
-27,785
-5% -$471K
CERS icon
243
Cerus
CERS
$530M
$9.04M 0.16%
1,530,026
+64,633
+4% +$379K
COMP icon
244
Compass
COMP
$9.66B
$8.89M 0.16%
+676,795
New +$10.6M
CDMO
245
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$8.49M 0.15%
+330,998
New +$7.07M
CYTK icon
246
Cytokinetics
CYTK
$10.8B
$8.39M 0.15%
424,175
-22,379
-5% -$525K
SWX icon
247
Southwest Gas
SWX
$6.65B
$8.23M 0.15%
124,348
-13,025
-9% -$889K
TRHC
248
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$8.07M 0.14%
161,366
-10,036
-6% -$449K
GLDD
249
DELISTED
Great Lakes Dredge & Dock
GLDD
$7.87M 0.14%
538,569
-56,523
-9% -$835K
AOS icon
250
A.O. Smith
AOS
$8.62B
$7.77M 0.14%
107,790
-5,748
-5% -$397K
8 9
10
11 12

Similar funds

CAM
Contour Asset Management New York $3.08B AUM 21.94% 1-Year Est. Return
MRCP
Maple Rock Capital Partners Toronto, Ontario, Canada $3.07B AUM 157.2% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
TCG
Tremblant Capital Group West Palm Beach, Florida $3.11B AUM 18.12% 1-Year Est. Return
CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
SAG
Susquehanna Advisors Group Bala Cynwyd, Pennsylvania $3.05B AUM 41.49% 1-Year Est. Return
EP
Edgestream Partners Princeton, New Jersey $3.05B AUM 12.73% 1-Year Est. Return

Peregrine Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Peregrine Capital Management held 368 positions worth $5.58B, up 3.4% from $5.39B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Peregrine Capital Management withdrew a net $168M in Q2 2021, closing 32 positions and reducing 177 holdings. Its most notable exit was Splunk Inc, an estimated $39.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Peregrine Capital Management opened a new position in Twilio worth $40.1M.

  • Peregrine Capital Management's largest Q2 2021 buy was Twilio: 101,821 shares worth $40.1M.
  • Peregrine Capital Management added most to Teladoc Health in Q2 2021, an estimated $18.8M increase.
  • Peregrine Capital Management's biggest Q2 2021 reduction was Webster Financial, cutting an estimated $23.4M.
  • Peregrine Capital Management fully exited Splunk Inc in Q2 2021, selling an estimated $39.1M.
  • Peregrine Capital Management's ten largest holdings make up 15% of its $5.58B portfolio in Q2 2021.
  • Peregrine Capital Management opened 29 new positions and closed 32 in Q2 2021.
  • Peregrine Capital Management's portfolio value rose 3.4% quarter-over-quarter to $5.58B.

Based on Peregrine Capital Management's 13F filing for Q2 2021, filed 3 Aug 2021.